Your browser doesn't support javascript.
loading
Chemoprophylaxis Effect of EGCG on the Recurrence of Colorectal Cancer: A Systematic Review and Meta-Analysis.
He, Benyu; Kang, Shuhui; Su, Runze; Wu, Sha; Liu, Xue; Liu, Maosheng; Chen, Si.
Afiliação
  • He B; Zunyi Medical University, Zhuhai Campus, Zhuhai, China.
  • Kang S; Zunyi Medical University, Zhuhai Campus, Zhuhai, China.
  • Su R; Zunyi Medical University, Zhuhai Campus, Zhuhai, China.
  • Wu S; Zunyi Medical University, Zhuhai Campus, Zhuhai, China.
  • Liu X; School of Nursing, Hebei University, Baoding, China.
  • Liu M; Zunyi Medical University, Zhuhai Campus, Zhuhai, China.
  • Chen S; Zunyi Medical University, Zhuhai Campus, Zhuhai, China.
Curr Pharm Des ; 2024 Jul 10.
Article em En | MEDLINE | ID: mdl-38988171
ABSTRACT
BACKGROUND AND

AIMS:

The recurrence rate of Colorectal Cancer (CRC) after cure is always high. The purpose of this study was to investigate whether green tea extract (-)-Epigallocatechin gallate (EGCG) has an effective preventive effect on the recurrence of CRC.

METHODS:

We conducted a systematic literature review and meta-analysis of the effects of taking EGCG or placebo on disease recurrence in patients after colon polyp removal.

RESULTS:

Five Randomized Controlled Trials (RCTs) were included in this review. A double-blind drug trial involving 1389 participants involved EGCG and placebo. The results showed no significant publication bias or heterogeneity in the five studies (I2 = 38%; p = 0.17). Patients taking EGCG had a lower recurrence rate of CRC than those in the placebo group. The results were statistically significant (Z=2.83, p < 0.05).

CONCLUSION:

This study demonstrated that long-term EGCG can prevent CRC recurrence to a certain extent.
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Ano de publicação: 2024 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Ano de publicação: 2024 Tipo de documento: Article